Xiaoyuan Chu

3.7k total citations · 1 hit paper
91 papers, 2.7k citations indexed

About

Xiaoyuan Chu is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Xiaoyuan Chu has authored 91 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Molecular Biology, 34 papers in Cancer Research and 27 papers in Oncology. Recurrent topics in Xiaoyuan Chu's work include Cancer-related molecular mechanisms research (22 papers), MicroRNA in disease regulation (20 papers) and Circular RNAs in diseases (18 papers). Xiaoyuan Chu is often cited by papers focused on Cancer-related molecular mechanisms research (22 papers), MicroRNA in disease regulation (20 papers) and Circular RNAs in diseases (18 papers). Xiaoyuan Chu collaborates with scholars based in China, United States and Australia. Xiaoyuan Chu's co-authors include Longbang Chen, Rui Wang, Cheng Chen, Liya Wang, Mengxi Huang, Haizhu Song, Zengjie Lei, Xiang Liu, Leilei Tao and Bing Feng and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiaoyuan Chu

87 papers receiving 2.7k citations

Hit Papers

Tumor organoid-immune co-... 2025 2026 2025 5 10 15
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Tumor organoid-immune co-culture models: exploring a new perspective of tumor immunity
    2025 19 citations Xiaoyuan Chu, Gongbo Fu et al. Cell Death Discovery profile →

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
Xiaoyuan Chu 2.0k 1.4k 557 272 198 91 2.7k
Beiqin Yu 2.0k 1.0× 1.6k 1.1× 476 0.9× 268 1.0× 188 0.9× 65 2.7k
Shujuan Ni 2.2k 1.1× 2.1k 1.4× 550 1.0× 309 1.1× 235 1.2× 61 2.9k
Li Zhou 1.5k 0.8× 1.0k 0.7× 905 1.6× 297 1.1× 324 1.6× 118 2.7k
Linlang Guo 2.5k 1.2× 1.6k 1.1× 824 1.5× 321 1.2× 118 0.6× 119 3.2k
Hee Jung An 1.3k 0.6× 766 0.5× 818 1.5× 382 1.4× 313 1.6× 76 2.5k
Ryou-u Takahashi 1.9k 1.0× 1.6k 1.1× 468 0.8× 121 0.4× 187 0.9× 22 2.5k
Amir Moghaddam 1.6k 0.8× 943 0.7× 1.2k 2.1× 218 0.8× 123 0.6× 20 2.5k
Judy Wai Ping Yam 1.8k 0.9× 769 0.5× 478 0.9× 210 0.8× 88 0.4× 94 2.4k
Giovanni Esposito 1.1k 0.5× 637 0.4× 768 1.4× 196 0.7× 245 1.2× 65 2.1k
Guo‐Ming Shi 1.8k 0.9× 1.2k 0.9× 740 1.3× 339 1.2× 446 2.3× 71 3.0k

Countries citing papers authored by Xiaoyuan Chu

Since Specialization
Citations

This map shows the geographic impact of Xiaoyuan Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoyuan Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoyuan Chu more than expected).

Fields of papers citing papers by Xiaoyuan Chu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaoyuan Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoyuan Chu. The network helps show where Xiaoyuan Chu may publish in the future.

Co-authorship network of co-authors of Xiaoyuan Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaoyuan Chu. A scholar is included among the top collaborators of Xiaoyuan Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaoyuan Chu. Xiaoyuan Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yang, Jiahe, et al.. (2025). The role of ankyrin repeat-containing proteins in epigenetic and transcriptional regulation. Cell Death Discovery. 11(1). 232–232.
2.
Song, Xueru, et al.. (2024). Transition Metal Oxide Nanomaterials: New Weapons to Boost Anti-Tumor Immunity Cycle. Nanomaterials. 14(13). 1064–1064. 6 indexed citations
3.
Wang, Jing, Gongbo Fu, Lan Ding, et al.. (2024). Survival analysis and prognostic model establishment of secondary osteosarcoma: a SEER-based study. Annals of Medicine and Surgery. 86(5). 2507–2517. 1 indexed citations
4.
5.
Zhao, Xiaoyue, Ying Zhang, Chunyan Zhu, Zhihui Yang, & Xiaoyuan Chu. (2024). Advanced surface-enhanced raman scattering nanoprobes for precise detection of Nitroreductase in Hypoxic tumor cells: Improving Cancer diagnosis. SLAS TECHNOLOGY. 30. 100229–100229. 2 indexed citations
6.
Yang, Fangyuan, et al.. (2024). Tertiary lymphoid structures: new immunotherapy biomarker. Frontiers in Immunology. 15. 1394505–1394505. 8 indexed citations
7.
Xiang, Dan, Mengxi Huang, Zhaochen Sun, et al.. (2024). Case report: Concurrent intrathecal and intravenous pembrolizumab for metastatic melanoma with leptomeningeal disease. Frontiers in Oncology. 14. 1344829–1344829. 2 indexed citations
8.
Yang, Jiahe, et al.. (2024). The impact of tumor size on the prognosis and chemotherapy efficacy in stage I/II colon cancer patients. Journal of Cancer. 15(15). 5020–5027. 1 indexed citations
9.
Tian, Chuan, et al.. (2021). Immune prognostic implications of PSMD14 and its associated genes signatures in hepatocellular carcinoma. Biocell. 45(6). 1527–1541. 2 indexed citations
10.
Ji, Xiaoqin, Chenglong He, Siqi Han, et al.. (2021). Clinical Effects of Stereotactic Body Radiation Therapy Targeting the Primary Tumor of Liver-Only Oligometastatic Pancreatic Cancer. Frontiers in Oncology. 11. 659987–659987. 9 indexed citations
11.
Huang, Mengxi, Chenglong He, Cheng Chen, et al.. (2021). Risk of Second Primary Malignancies Based on the Histological Subtypes of Colorectal Cancer. Frontiers in Oncology. 11. 650937–650937. 3 indexed citations
12.
Tang, Xinyi, Mengxi Huang, Siqi Han, et al.. (2020). The Circumferential Resection Margin Is a Prognostic Predictor in Colon Cancer. Frontiers in Oncology. 10. 927–927. 11 indexed citations
13.
Xue, Lijun, Xiaobei Mao, Xiaobei Liu, et al.. (2019). Activation of CD3+ T cells by Helicobacter pylori DNA vaccines in potential immunotherapy of gastric carcinoma. Cancer Biology & Therapy. 20(6). 866–876. 16 indexed citations
14.
15.
Zhi, Yingru, Hao Zhou, Ting Wang, et al.. (2019). FOXM1-Mediated LINC-ROR Regulates the Proliferation and Sensitivity to Sorafenib in Hepatocellular Carcinoma. Molecular Therapy — Nucleic Acids. 16. 576–588. 45 indexed citations
16.
Chen, Jing, Yuejuan Xu, Leilei Tao, et al.. (2017). MiRNA-26a Contributes to the Acquisition of Malignant Behaviors of Doctaxel-Resistant Lung Adenocarcinoma Cells through Targeting EZH2. Cellular Physiology and Biochemistry. 41(2). 583–597. 40 indexed citations
17.
Gao, Yanping, Jun Yi, Kai Zhang, et al.. (2017). Downregulation of MiR-31 stimulates expression of LATS2 via the hippo pathway and promotes epithelial-mesenchymal transition in esophageal squamous cell carcinoma. Journal of Experimental & Clinical Cancer Research. 36(1). 161–161. 50 indexed citations
18.
Xie, Tao, Jian Geng, Ye Wang, et al.. (2016). FOXM1 evokes 5-fluorouracil resistance in colorectal cancer depending on ABCC10. Oncotarget. 8(5). 8574–8589. 59 indexed citations
19.
Qu, Le, Zhenjie Wu, Yaoming Li, et al.. (2016). A feed-forward loop between lncARSR and YAP activity promotes expansion of renal tumour-initiating cells. Nature Communications. 7(1). 12692–12692. 97 indexed citations
20.
Chu, Xiaoyuan, Ziman Zhu, Longbang Chen, et al.. (2012). FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer. Acta Histochemica. 114(8). 755–762. 79 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Beiqin Yu Breakdown of academic impact, for papers by Shujuan Ni Breakdown of academic impact, for papers by Li Zhou Breakdown of academic impact, for papers by Linlang Guo Breakdown of academic impact, for papers by Hee Jung An Breakdown of academic impact, for papers by Ryou-u Takahashi Breakdown of academic impact, for papers by Amir Moghaddam Breakdown of academic impact, for papers by Judy Wai Ping Yam Breakdown of academic impact, for papers by Giovanni Esposito Breakdown of academic impact, for papers by Guo‐Ming Shi
Rankless by CCL
2026